MBX
MBX Biosciences, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.36B
P/E Ratio
—
EPS
$-2.38
Beta
—
52W High
$44.89
52W Low
$9.43
50-Day MA
$31.50
200-Day MA
$25.06
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About MBX Biosciences, Inc. Common Stock
MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. The company is headquartered in Carmel, Indiana.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-97.81M |
| Operating Margin | 0.00% |
| Return on Equity | -27.80% |
| Return on Assets | -18.80% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $8.22 |
| Price-to-Book | 3.69 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $47.57M |
| Float | $29.03M |
| % Insiders | 2.68% |
| % Institutions | 104.73% |
Historical Volatility
HV 10-Day
53.18%
HV 20-Day
66.16%
HV 30-Day
66.64%
HV 60-Day
69.42%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($62.55 target)
2
Strong Buy9
Buy1
SellData last updated: 4/30/2026